financetom
Business
financetom
/
Business
/
Genworth Financial Plans New $350 Million Share Repurchase Program
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Genworth Financial Plans New $350 Million Share Repurchase Program
Sep 20, 2025 8:51 PM

04:33 PM EDT, 09/18/2025 (MT Newswires) -- Genworth Financial ( GNW ) said late Thursday that its board has authorized new share buyback of up to $350 million of common stock, with no set expiration date.

The new authorization supplements Genworth's ( GNW ) $700 million repurchase program, which had $16 million still available as of Sep. 17, the company said.

The repurchases may be carried out via open market purchases, private deals, or through SEC Rule 10b5-1 trading plans, it added.

The company's shares were up over 1% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Devon Energy to Buy Grayson Mill's Williston Basin Business for $5 Billion
Update: Devon Energy to Buy Grayson Mill's Williston Basin Business for $5 Billion
Jul 8, 2024
07:56 AM EDT, 07/08/2024 (MT Newswires) -- (Updates with details in second and third paragraphs.) Devon Energy ( DVN ) said Monday it has entered into a definitive purchase agreement to acquire Grayson Mill Energy's Williston Basin operations in a deal valued at $5 billion. The company said it will fund the acquisition with $3.25 billion of cash and 37...
iTeos Therapeutics Doses First Patient in Phase 3 Trial of Belrestotug With Dostarlimab; Triggers $35 Million GSK Payment
iTeos Therapeutics Doses First Patient in Phase 3 Trial of Belrestotug With Dostarlimab; Triggers $35 Million GSK Payment
Jul 8, 2024
07:54 AM EDT, 07/08/2024 (MT Newswires) -- iTeos Therapeutics ( ITOS ) said Monday it has dosed the first patient in its phase 3 trial of belrestotug with dostarlimab, triggering a $35 million development milestone payment from its belrestotug partner GSK (GSK). The global, randomized, double-blind trial aims to compare the efficacy of belrestotug with dostarlimab against a placebo combined...
Top Premarket Decliners
Top Premarket Decliners
Jul 8, 2024
07:50 AM EDT, 07/08/2024 (MT Newswires) -- Beneficient (BENF) shares fell 15% Monday premarket after more than doubling on Friday. Koss Corporation ( KOSS ) shares were down 14%, shaving Friday's gains. Shineco ( SISI ) shares dropped 10%, reversing gains from the previous session. Price: 4.0800, Change: -0.76, Percent Change: -15.70 ...
Market Chatter: KKR Reportedly Looking to Revive Sale of Goodpack
Market Chatter: KKR Reportedly Looking to Revive Sale of Goodpack
Jul 8, 2024
07:55 AM EDT, 07/08/2024 (MT Newswires) -- KKR & Co ( KKR ) is considering the revival of the sale of Singapore-based global supply chain and logistics company Goodpack in a potentially multibillion-dollar deal, The Wall Street Journal reported Monday, citing people familiar with the plan. The sources said that the private-equity firm is in early discussions with advisers to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved